lorazepam has been researched along with Paralysis, Legs in 1 studies
Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Serum concentration-time course profiles, serum protein binding, and disposition parameters of lorazepam (LRZ), a benzodiazepine with sedative-hypnotic, anxiolytic, and anti-seizure properties, were studied as part of a systematic effort to define population-specific pharmacokinetic behavior in humans with chronic spinal cord injury (SCI)." | 1.28 | Decreased systemic clearance of lorazepam in humans with spinal cord injury. ( Brunnemann, SR; Eltorai, IM; Segal, JL; Vulpe, M, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Segal, JL | 1 |
| Brunnemann, SR | 1 |
| Eltorai, IM | 1 |
| Vulpe, M | 1 |
1 other study available for lorazepam and Paralysis, Legs
| Article | Year |
|---|---|
Decreased systemic clearance of lorazepam in humans with spinal cord injury.
Topics: Adult; Blood Proteins; Humans; Infusions, Intravenous; Lorazepam; Male; Metabolic Clearance Rate; Mi | 1991 |